FastSwings.com

   Stocks, Stock Swings, Options, and Option Trades

   Disclaimer: Consult a Financial Advisor prior to taking the advice offered. By reading this blog site you agree to not hold any authors or FastSwings.com responsible for market loses that you may incur.

 Subscribe in a reader

Subscribe to FastSwings by Email



Genetech Inc. March Calls

Feb 22 2008

Genetech Inc. (DNA) March options in the 70, 75, and 80 calls are being purchased with high volume today ahead of a FDA decision. Genetech investors are awaiting the FDA’s decision on weather to allow Avastin for breast cancer treatments, which could be released sometime today. The FDA Advisory Committee voted 5-4 against recommending approval of Avastin for breast cancer treatment. Rumors are that two members who voted against the decision have reconsidered their positions. Playing it safe and still getting the upside if the FDA votes in favor of Genetech, you would purchase some March 70 calls.

Our FaceBook Page

Market Summary

Translate

Sponsors





Categories